MiMedx Group, Inc. (MDXG) stock
MDXGNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 12/3036% below fair value
$3.05−0.06 (-1.93%)
Close on Nov 20, 2026Market cap $445.07MP/E –Yield –
MiMedx shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
MiMedx's shares outstanding was 146M at Sep 30, 2026. For fiscal 2025 it was 150M, up 0.5% from the year before. Over ten years it grew 2.8% a year on average. The highest annual figure on record is 150M in fiscal 2025.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 150M | +0.5% |
| FY2024 | Dec 31, 2024 | 149M | +2.1% |
| FY2023 | Dec 31, 2023 | 146M | +29.3% |
| FY2022 | Dec 31, 2022 | 113M | +2.3% |
| FY2021 | Dec 31, 2021 | 110M | +1.9% |
| FY2020 | Dec 31, 2020 | 108M | +1.2% |
| FY2019 | Dec 31, 2019 | 107M | +1.3% |
| FY2018 | Dec 31, 2018 | 106M | -9.1% |
| FY2017 | Dec 31, 2017 | 116M | +3.1% |
| FY2016 | Dec 31, 2016 | 113M | -0.9% |
| FY2015 | Dec 31, 2015 | 114M | +0.3% |
| FY2014 | Dec 31, 2014 | 113M | +17.7% |
| FY2013 | Dec 31, 2013 | 96M | +17.9% |
| FY2012 | Dec 31, 2012 | 82M | +12.7% |
| FY2011 | Dec 31, 2011 | 72M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 146M | -2.6% |
| Q2 FY2026 | Jun 30, 2026 | 148M | -1.0% |
| Q1 FY2026 | Mar 31, 2026 | 148M | -0.8% |
| Q4 FY2025 | Dec 31, 2025 | 150M | +0.6% |
| Q3 FY2025 | Sep 30, 2025 | 150M | +0.9% |
| Q2 FY2025 | Jun 30, 2025 | 149M | +0.3% |
| Q1 FY2025 | Mar 31, 2025 | 150M | -0.2% |
| Q4 FY2024 | Dec 31, 2024 | 149M | -36.0% |
| Q3 FY2024 | Sep 30, 2024 | 148M | -0.9% |
| Q2 FY2024 | Jun 30, 2024 | 149M | +1.4% |
| Q1 FY2024 | Mar 31, 2024 | 150M | +31.1% |
| Q4 FY2023 | Dec 31, 2023 | 233M | +105.1% |
| Q3 FY2023 | Sep 30, 2023 | 150M | +32.0% |
| Q2 FY2023 | Jun 30, 2023 | 147M | +30.1% |
| Q1 FY2023 | Mar 31, 2023 | 114M | +2.5% |
| Q4 FY2022 | Dec 31, 2022 | 114M | +2.4% |
| Q3 FY2022 | Sep 30, 2022 | 113M | +2.5% |
| Q2 FY2022 | Jun 30, 2022 | 113M | +2.3% |
| Q1 FY2022 | Mar 31, 2022 | 112M | +2.0% |
| Q4 FY2021 | Dec 31, 2021 | 111M | +2.4% |
| Q3 FY2021 | Sep 30, 2021 | 111M | +2.0% |
| Q2 FY2021 | Jun 30, 2021 | 110M | +2.0% |
| Q1 FY2021 | Mar 31, 2021 | 109M | +1.7% |
| Q4 FY2020 | Dec 31, 2020 | 108M | +1.3% |
| Q3 FY2020 | Sep 30, 2020 | 108M | -1.0% |
| Q2 FY2020 | Jun 30, 2020 | 108M | +1.1% |
| Q1 FY2020 | Mar 31, 2020 | 108M | +1.1% |
| Q4 FY2019 | Dec 31, 2019 | 107M | +12.8% |
| Q3 FY2019 | Sep 30, 2019 | 110M | +3.4% |
| Q2 FY2019 | Jun 30, 2019 | 107M | -3.7% |
| Q1 FY2019 | Mar 31, 2019 | 106M | -6.4% |
| Q4 FY2018 | Dec 31, 2018 | 95M | -17.4% |
| Q3 FY2018 | Sep 30, 2018 | 106M | -9.8% |
| Q2 FY2018 | Jun 30, 2018 | 111M | -5.3% |
| Q1 FY2018 | Mar 31, 2018 | 114M | -0.0% |
| Q4 FY2017 | Dec 31, 2017 | 115M | +0.7% |
| Q3 FY2017 | Sep 30, 2017 | 118M | – |
| Q2 FY2017 | Jun 30, 2017 | 117M | – |
| Q1 FY2017 | Mar 31, 2017 | 114M | – |
| Q4 FY2016 | Dec 31, 2016 | 114M | – |
See a number that looks wrong?